1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Intravenous Immunoglobulin Market
2.2. Global Intravenous Immunoglobulin Market, By Indication, 2024 (US$ Million)
2.3. Global Intravenous Immunoglobulin Market, By End-user, 2024 (US$ Million)
2.4. Global Intravenous Immunoglobulin Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Intravenous Immunoglobulin Market: Competitive Analysis
3.1. Market Positioning of Key Intravenous Immunoglobulin Market Vendors
3.2. Strategies Adopted by Intravenous Immunoglobulin Market Vendors

4. Intravenous Immunoglobulin Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Intravenous Immunoglobulin Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape

5. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3.2. Primary Humoral Immunodeficiency
5.3.3. Idiopathic Thrombocytopenic Purpura (ITP)
5.3.4. Guillain-Barre Syndrome
5.3.5. Myasthenia Gravis
5.3.6. Multifocal Motor Neuropathy (MMN)
5.3.7. Kawasaki Disease
5.3.8. Hypogammaglobulinemia
5.3.9. Chronic Lymphocytic Leukemia
5.3.10. Others

6. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Care


7. North America Intravenous Immunoglobulin Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
7.3. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
7.4.Intravenous Immunoglobulin Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
7.4.1.1.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
7.4.1.2.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
7.4.1.3.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)

8. UK and European Union Intravenous Immunoglobulin Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.3. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
8.4.Intravenous Immunoglobulin Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.4.1.1.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.4.1.2.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.4.1.3.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.4.1.4.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.4.1.5.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
8.4.1.6.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)

9. Asia Pacific Intravenous Immunoglobulin Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.3. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
9.4.Intravenous Immunoglobulin Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.4.1.1.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.4.1.2.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.4.1.3.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.4.1.4.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.4.1.5.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
9.4.1.6.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)

10. Latin America Intravenous Immunoglobulin Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
10.3. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
10.4.Intravenous Immunoglobulin Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
10.4.1.1.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
10.4.1.2.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
10.4.1.3.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)

11. Middle East and Africa Intravenous Immunoglobulin Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
11.3. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
11.4.Intravenous Immunoglobulin Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
11.4.1.1.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
11.4.1.2.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Intravenous Immunoglobulin Market: By Indication, 2023-2033, USD (Million)
11.4.1.3.2. Intravenous Immunoglobulin Market: By End-user, 2023-2033, USD (Million)

12. Company Profile
12.1. Baxalta Incorporated (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Biotest AG
12.3. China Biologic Products, Inc.
12.4. CSL Behring LLC
12.5. Grifols S.A.
12.6. Kedrion S.p.A.
12.7. LFB Biomedicaments S.A.
12.8. Octapharma AG
12.9. Sanquin Plasma Products B.V.
12.10. Other Notable Players